Revised Manufacturing Rules For Industry
Source: Indian Express
GS II: Governance
Overview
- News in Brief
- Why standardisation needed?
- Revised Manufacturing Rules For Industry
Why in News?
The country’s pharmaceutical industries have lately been ordered by the government to adopt the updated Good Manufacturing Practices (GMP), putting their procedures in line with international standards.
News in Brief
- The adjustments must be implemented by larger businesses with a revenue of more than Rs 250 crore within six months, and by medium- and small-sized businesses with a turnover of less than Rs 250 crore within a year.
- The new standards’ implementation will bring Indian industry standards up to level with those used worldwide.
Why standardisation needed?
- In a series of incidences, syrups, eye drops, and eye ointments made in India have allegedly been contaminated, according to reports from various nations.
- For instances these goods have been implicated in the deaths of three people in the US, 70 children in the Gambia, 18 in Uzbekistan, and six in Cameroon.
- Only 2,000 of the country’s 10,500 drug production facilities now adhere to international norms.
- Besides a risk-based inspection of 162 manufacturing units by the government found several deficiencies
- Incoming raw materials not being tested before use
- Product quality not being reviewed
- Absence of quality failure investigation
- Infrastructure deficiency to prevent cross-contamination
- Faulty design of manufacturing and testing areas
- Missing qualified professionals
- Poor documentation.
How improved standard Helps?
The improved standards will ensure that pharmaceutical companies follow standard processes, quality control measures, and do not cut corners, improving quality of medicines available in India as well as sold in global market.
What are the revised Good Manufacturing practices?
- Quality
- To ensure the quality of medications manufactured, put an emphasis on quality control procedures, accurate paperwork, and IT support.
- Companies will have to carry out pharmaceutical quality system, quality risk management, product quality review, and validation of equipment.
- Stability studies
- The companies will also have to carry out stability studies as per the climate conditions.
- Majority of companies already preserve their samples in accordance with prescribed guidelines and periodically test for different criteria.
- Now, they will be needed to mandatorily maintain the drugs in a stability chamber, set the proper temperature and humidity, and carry out an accelerated stability test as well.
- Computerised Systems
- It is important for companies to have computerized systems that comply with GMP regulations.
- This ensures that no data related to processes can be tampered with.
- By implementing GMP systems, unauthorized access and changes to data can be prevented.
- Additionally, there are controls in place to prevent any omission of data.
- If any sensitive data is manually entered into the system, there are additional checks to ensure its accuracy.
- These computer programs are designed to automatically record all steps taken and checks performed.
Implementation
- Implementation would start on August 1 and go through August 31, giving larger businesses six months and smaller businesses a year to execute the changes.
Drug Manufacturing In India
- Drug manufacturing in India is a significant and thriving industry with both domestic and global impact.
- India has established itself as a major player in the pharmaceutical sector, known for producing a wide range of drugs, including generic medications, active pharmaceutical ingredients (APIs), and formulations.
- The industry has evolved over the years and plays a crucial role in providing affordable healthcare solutions to both domestic and international markets.
About drug manufacturing in India
- Generic Drug Production:
- India is a leading producer of generic drugs, which are more affordable alternatives to brand-name medications.
- This has contributed to making healthcare more accessible and cost-effective, both within India and in other countries.
- Active Pharmaceutical Ingredients (APIs)
- India is a major supplier of APIs, which are the essential components of medications.
- The country produces a significant portion of the world’s APIs, contributing to the global pharmaceutical supply chain.
- Export-Oriented Industry
- The Indian pharmaceutical industry is heavily export-oriented, with a substantial portion of its products being exported to various countries.
- India’s pharmaceutical exports include finished formulations, APIs, intermediates, and other healthcare products.
- Regulatory Framework
- The industry is regulated by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare, Government of India.
- The CDSCO ensures that drugs manufactured and sold in India meet safety, efficacy, and quality standards.
- World Health Organization (WHO) Prequalification
- Many Indian pharmaceutical companies have received the WHO prequalification, which allows them to supply medicines to international organizations like UNICEF and WHO for global health programs.
- Investment in Research and Development (R&D)
- India has been investing in pharmaceutical research and development, leading to innovations in drug formulations and production processes.
- Some Indian pharmaceutical companies have also developed their own new drugs.
- Intellectual Property and Patent Challenges
- India has had discussions and debates with regards to intellectual property rights, especially in the context of patent laws.
- There have been cases where Indian pharmaceutical companies have challenged patents of multinational corporations, leading to debates about accessibility to medicines.
- Quality Control and Compliance
- While the Indian pharmaceutical industry has made significant strides in quality control and compliance with international standards, there have been instances of regulatory concerns related to manufacturing practices and quality control.
- Pharmaceutical Parks and Clusters
- Several pharmaceutical parks and clusters have been established in India to provide a conducive environment for pharmaceutical manufacturing.
- These parks offer infrastructure, shared facilities, and regulatory support.
- COVID-19 Pandemic Response
- During the COVID-19 pandemic, Indian pharmaceutical companies played a critical role in producing and supplying essential medications
- This including COVID-19 treatments and vaccines, not only for domestic use but also for global distribution through initiatives like COVAX.
Conclusion
- India’s drug manufacturing industry stands as a driving force in the global pharmaceutical arena.
- Through its commitment to quality, innovation, and affordability, the sector plays a pivotal role in providing healthcare solutions to people worldwide.
- As the industry continues to evolve and address challenges, its contributions to healthcare accessibility and advancement remain undeniable.
Daily Current Affairs: Click Here